NCT07508852RecruitingPhase 1/2
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
Targeting Delta-like Ligand 3 (DLL3) With 68Ga-PFD3 PET/CT for the Diagnosis and Assessment of Small Cell Lung Cancer (SCLC)
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
This study aims to investigate and evaluate the safety and performance of a novel probe, PFD3, for the diagnosis and assessment of patients with small cell lung cancer (SCLC).
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 21 Mar 2026
- Start date
- 22 Oct 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Peking University First Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07508852
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 30
- From 22 Oct 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior therapy targeting DLL3.
Other illness
- Acute psychiatric disorders.
Other
- Pregnancy.
- Breastfeeding.
- Inability to undergo PET scanning (e.g., due to claustrophobia, weight limits, or other medical contraindications).
- Inability to complete the study procedures as anticipated.
Who the study is looking for
- Adults.
- Histologically confirmed small cell lung cancer (SCLC).
- At least one measurable lesion ≥1 cm in diameter (primary tumor, metastatic lesion, or involved lymph node) confirmed by standard imaging modalities.
- Laboratory tests (complete blood count and biochemical analysis) completed within 4 weeks prior to enrollment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking university first hospital nuclear medicine Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.